NFE2L2 and pulmonary fibrosis: Our findings suggested that bergenin could be a therapeutic agent for pulmonary fibrosis treatment, and we propose that the p62–Nrf2 regulatory loop may be a potential therapeutic target for pulmonary fibrosis.